---
title: "ESSA Pharma Reports Q1 Loss, Explores Strategic Options"
date: "2025-02-11 20:50:58"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioESSA Pharma ( (EPIX) ) just..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1549769756-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

ESSA Pharma ( [(EPIX)](https://www.tipranks.com/stocks/epix) ) just unveiled an update.

ESSA Pharma has reported a net loss of $8.5 million for the first fiscal quarter of 2025, following the termination of its masofaniten clinical trials. The company is exploring several strategic options, such as mergers or asset sales, to maximize shareholder value, which may involve cost reductions.

**More about ESSA Pharma**

ESSA Pharma Inc. is a pharmaceutical company that was focused on developing novel therapies for the treatment of prostate cancer before discontinuing its clinical trials and development programs.

**YTD Price Performance:** -9.29%

**Average Trading Volume:** 323,889

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** $75.02M

Find detailed analytics on EPIX stock on [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/epix/stock-analysis).

Trending Articles:
------------------

* [Elon Musk’s Brother and Tesla Director Kimbal Sells $28M Worth of Stock](https://www.tipranks.com/news/elon-musks-brother-and-tesla-director-kimbal-sells-28m-worth-of-stock)
* [APLT Lawsuit Alert! Class Action Against Applied Therapeutics, Inc.](https://www.tipranks.com/news/aplt-lawsuit-alert-class-action-against-applied-therapeutics-inc)
* [‘Bullish Confirmation Coming,’ Says Investor About Super Micro Computer Stock](https://www.tipranks.com/news/bullish-confirmation-coming-says-investor-about-super-micro-computer-stock)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/essa-pharma-reports-q1-loss-explores-strategic-options)
